Bispecific Antibodies for the Treatment of Multiple Myeloma

被引：0
|
作者：
Scott R. Goldsmith
Shawn Streeter
Fahrettin Covut
机构：
[1] Judy and Bernard Briskin Center for Multiple Myeloma Research,Division of Oncology
[2] City of Hope Comprehensive Cancer Center,undefined
[3] Washington University School of Medicine,undefined
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Bispecific antibodies; Bispecific T-cell engagers; Multiple myeloma; Immunotherapy; BCMA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：286 / 297
页数：11
相关论文
共 50 条
  • [11] Sequencing of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma
    Shewan, Samuel
    Steinbach, Mary
    Julian, Kelley
    Fortuna, Gliceida Galarza
    Vigil, Meghan
    Maxwell, Linsday
    Parkin, Eliza
    Wagner, Charlotte
    Mohyuddin, Manni
    Godara, Amandeep
    McClune, Brian
    Sborov, Douglas W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S88 - S88
  • [12] Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma
    Tacchetti, Paola
    Barbato, Simona
    Mancuso, Katia
    Zamagni, Elena
    Cavo, Michele
    CANCERS, 2024, 16 (13)
  • [13] Current use of bispecific antibodies to treat multiple myeloma
    Lee, Holly
    Neri, Paola
    Bahlis, Nizar J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 332 - 339
  • [14] Bispecific antibodies for multiple myeloma: past, present and future
    Ochi, Toshiki
    Konishi, Tatsuya
    Takenaka, Katsuto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 23 - 33
  • [15] Bispecific antibodies in myeloma
    Le Grand, Sophie
    Perrot, Aurore
    HEMATOLOGIE, 2021, 27 : 19 - 25
  • [16] Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
    Tai, Waqqas
    Wahab, Ahsan
    Franco, Diana
    Shah, Zunairah
    Ashraf, Aqsa
    Abid, Qurrat-Ul-Ain
    Mohammed, Yaqub Nadeem
    Lal, Darshan
    Anwer, Faiz
    ANTIBODIES, 2022, 11 (02)
  • [17] Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
    Dalla Palma, Benedetta
    Marchica, Valentina
    Catarozzo, Maria Teresa
    Giuliani, Nicola
    Accardi, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [18] T-CELL BISPECIFIC ANTIBODIES SUPPRESS MULTIPLE MYELOMA
    Seckinger, A.
    Delgado, J. A.
    Moser, S.
    Moreno, L.
    Neuber, B.
    Grab, A.
    Li, J.
    Stagg, N. J.
    Johnston, J.
    Harris, M. J.
    Menzies, S. A.
    DiCara, D.
    CANCER DISCOVERY, 2017, 7 (05) : 452 - 452
  • [19] Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma
    Saez, Adolfo
    Lopez-Munoz, Nieves
    Maria Sanchez-Pina, Jose
    Alonso, Rafael
    Cuellar, Clara
    Lazaro, Paula
    Jimenez Ubieto, Ana
    Calbacho, Maria
    Martinez Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S97 - S98
  • [20] Clinical Outcomes of Relapsed/Refractory Multiple Myeloma Patients Following Treatment with Bispecific Antibodies (BiAbs)
    Mouhieddine, Tarek H.
    Van Oekelen, Oliver
    Pan, Darren
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David T.
    Lancman, Guido
    Thibaud, Santiago
    Sanchez, Larysa
    Richard, Shambavi
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    BLOOD, 2021, 138
12345